Search Results - Manuel Gotti

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIM... by Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori

    Get full text
    Article


  2. 2

    THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LI... by Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori

    Get full text
    Article


  3. 3

    THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LI... by Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori

    Get full text
    Article


  4. 4

    THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LI... by Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori

    Get full text
    Article


  5. 5

    Prognostic Assessment in Patients with Indolent B-Cell Lymphomas by Luca Arcaini, Sara Rattotti, Manuel Gotti, Stefano Luminari

    Published in The Scientific World Journal (2012-01-01)
    Get full text
    Article


  6. 6

    Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy by Luca Arcaini, Michele Merli, Stefano Volpetti, Sara Rattotti, Manuel Gotti, Francesco Zaja

    Published in Clinical and Developmental Immunology (2012-01-01)
    Get full text
    Article


  7. 7

    P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report by Caterina Zerbi, Tanja Lazic, Roberta Sciarra, Caterina Cristinelli, Alessandro Mazzacane, Federico Carpi, Virginia Valeria Ferretti, Giulia Gambini, Maurizio Bonfichi, Luca Arcaini, Manuel Gotti

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  8. 8

    Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia by Elisa Rumi, Irene Bertozzi, Ilaria C. Casetti, Elisa Roncoroni, Chiara Cavalloni, Marta Bellini, Emanuela Sant’Antonio, Manuel Gotti, Virginia V. Ferretti, Chiara Milanesi, Edoardo Peroni, Daniela Pietra, Cesare Astori, Maria Luigia Randi, Mario Cazzola

    Published in Haematologica (2015-11-01)
    Get full text
    Article


  9. 9

    Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma by Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Manuela Zanni, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Francesca Ricci, Carmelo Carlo-Stella

    Published in Blood Advances (2020-01-01)
    Get full text
    Article


  10. 10

    Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi by Michele Merli, Carlo Visco, Michele Spina, Stefano Luminari, Virginia Valeria Ferretti, Manuel Gotti, Sara Rattotti, Valeria Fiaccadori, Chiara Rusconi, Clara Targhetta, Caterina Stelitano, Alessandro Levis, Achille Ambrosetti, Davide Rossi, Luigi Rigacci, Alfonso Maria D’Arco, Pellegrino Musto, Annalisa Chiappella, Luca Baldini, Maurizio Bonfichi, Luca Arcaini

    Published in Haematologica (2014-03-01)
    Get full text
    Article


  11. 11

    T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri... by Andrea Gallamini, Marco Picardi, Kateryna Filonenko, Manuel Gotti, Javier Núñez Céspedes, Andrea Rossi, Eva Domingo-Domènech, Agnieszka Giza, Roberto Sorasio, Livio Trentin, Mariana Bastos Oteiro, Ewa Paszkiewicz-Kozik, Ramon García Sanz, Caterina Patti, Stephane Chauvie, Fabrizio Bergesio, Luca Guerra, Alessandro Rambaldi, Ana Sureda Balari, Jan Maciej Zaucha

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  12. 12

    The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection by Luca Arcaini, Davide Rossi, Marco Lucioni, Marta Nicola, Alessio Bruscaggin, Valeria Fiaccadori, Roberta Riboni, Antonio Ramponi, Virginia V. Ferretti, Stefania Cresta, Gloria Margiotta Casaluci, Maurizio Bonfichi, Manuel Gotti, Michele Merli, Aldo Maffi, Mariarosa Arra, Marzia Varettoni, Sara Rattotti, Lucia Morello, Maria Luisa Guerrera, Roberta Sciarra, Gianluca Gaidano, Mario Cazzola, Marco Paulli

    Published in Haematologica (2015-02-01)
    Get full text
    Article


  13. 13

    Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi by Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi, Luca Arcaini

    Published in HemaSphere (2023-04-01)
    Get full text
    Article


Search Tools: